Systemic Light-chain Amyloidosis

• CLINICAL_TRIALS research · 2026-01-02
  Clinical Trial Update: Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients [Phase 1, Phase 2]

  This document describes an ongoing Phase 1/2 clinical trial evaluating the efficacy and safety of injectable TQB2934 for systemic light-chai…

• CLINICAL_TRIALS research · 2025-09-18
  Clinical Trial Update: A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) [Phase 1, Phase 2]

  Clinical trial update for Linvoseltamab in adults with relapsed or refractory systemic light-chain (AL) amyloidosis, currently recruiting in…

• CLINICAL_TRIALS research · 2025-01-31
  Clinical Trial Update: The Impact of Systemic Light Chain Amyloidosis on Eyes

  A clinical trial is recruiting to evaluate the impact of systemic light-chain (AL) amyloidosis on the eyes and associated ocular complicatio…